JPWO2023034564A5 - - Google Patents

Info

Publication number
JPWO2023034564A5
JPWO2023034564A5 JP2024513937A JP2024513937A JPWO2023034564A5 JP WO2023034564 A5 JPWO2023034564 A5 JP WO2023034564A5 JP 2024513937 A JP2024513937 A JP 2024513937A JP 2024513937 A JP2024513937 A JP 2024513937A JP WO2023034564 A5 JPWO2023034564 A5 JP WO2023034564A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
set forth
sequence set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024513937A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533162A5 (https=
JP2024533162A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/042448 external-priority patent/WO2023034564A2/en
Publication of JP2024533162A publication Critical patent/JP2024533162A/ja
Publication of JP2024533162A5 publication Critical patent/JP2024533162A5/ja
Publication of JPWO2023034564A5 publication Critical patent/JPWO2023034564A5/ja
Pending legal-status Critical Current

Links

JP2024513937A 2021-09-02 2022-09-02 抗ｃｄ３３抗体及びその使用 Pending JP2024533162A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163240220P 2021-09-02 2021-09-02
US63/240,220 2021-09-02
PCT/US2022/042448 WO2023034564A2 (en) 2021-09-02 2022-09-02 Anti-cd33 antibodies and uses thereof

Publications (3)

Publication Number Publication Date
JP2024533162A JP2024533162A (ja) 2024-09-12
JP2024533162A5 JP2024533162A5 (https=) 2025-09-09
JPWO2023034564A5 true JPWO2023034564A5 (https=) 2025-09-09

Family

ID=85412855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513937A Pending JP2024533162A (ja) 2021-09-02 2022-09-02 抗ｃｄ３３抗体及びその使用

Country Status (7)

Country Link
US (1) US20240262910A1 (https=)
EP (1) EP4396235A4 (https=)
JP (1) JP2024533162A (https=)
CN (1) CN118234750A (https=)
AU (1) AU2022340645A1 (https=)
CA (1) CA3228414A1 (https=)
WO (1) WO2023034564A2 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008535823A (ja) * 2005-03-25 2008-09-04 キュラジェン コーポレイション テネイシンの主要な抗原に対する抗体
DK2356270T3 (da) * 2008-11-07 2016-12-12 Fabrus Llc Kombinatoriske antistofbiblioteker og anvendelser deraf
JO3246B1 (ar) * 2009-09-09 2018-03-08 Regeneron Pharma اجسام مضادة بشرية ذات ألفة تفاعل عالية مع مستقبل 2 المفعل بالبروتين البشري
JP6488520B2 (ja) * 2013-08-20 2019-03-27 国立研究開発法人科学技術振興機構 ヒト抗体κ型軽鎖複合体含有組成物及びその製造方法
TWI702229B (zh) * 2014-12-19 2020-08-21 美商再生元醫藥公司 流行性感冒病毒血球凝集素之人類抗體
AU2017252233A1 (en) * 2016-04-22 2018-11-15 Alligator Bioscience Ab Novel bispecific polypeptides against CD137
JOP20190116A1 (ar) * 2018-05-24 2019-11-24 Janssen Biotech Inc الأجسام المضادة لتكتل التمايز 33 (cd33)، والأجسام المضادة ثنائية النوعية لتكتل التمايز 33 (cd33)/تكتل التمايز 3 (cd3) واستخداماتها
JP7303314B2 (ja) * 2019-01-18 2023-07-04 ヤンセン バイオテツク，インコーポレーテツド Ｇｐｒｃ５ｄキメラ抗原受容体及びそれを発現する細胞

Similar Documents

Publication Publication Date Title
DK2220121T3 (en) AXL antibodies
JP2022101693A5 (https=)
CN102741282B (zh) 针对转铁蛋白受体的抗体以及其用于依赖于铁的肿瘤的免疫疗法的用途
JP2020501531A5 (https=)
JP2018500014A5 (https=)
JP2020502271A5 (https=)
JP2008546780A5 (https=)
JP2019508013A5 (https=)
JP2011501656A5 (https=)
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
JP2020527332A5 (https=)
JP2021514945A5 (https=)
JP2010537671A5 (https=)
JPWO2019224711A5 (https=)
JP2010504755A5 (https=)
TW201026325A (en) Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
JP2021528047A5 (https=)
JP2024016024A5 (https=)
JP2013534515A5 (ja) 受容体型チロシンキナーゼｃ−Ｍｅｔに対する抗体
JP2007526908A5 (https=)
JPWO2019165340A5 (https=)
JPWO2021180205A5 (https=)
JP2009544574A5 (https=)
JP2025524306A (ja) Ｉｔｇａ２を標的とする抗体及びそれを含む抗体薬物複合体
JP2022513437A5 (https=)